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Abstract
Frailty is a geriatric syndrome characterised by a vulnerability status associated with declining function of multiple
physiological systems and loss of physiological reserves. Two main models of frailty have been advanced: the phenotypic
model (primary frailty) or deficits accumulation model (secondary frailty), and different instruments have been proposed
and validated to measure frailty. However measured, frailty correlates to medical outcomes in the elderly, and has been
shown to have prognostic value for patients in different clinical settings, such as in patients with coronary artery disease,
after cardiac surgery or transvalvular aortic valve replacement, in patients with chronic heart failure or after left ven-
tricular assist device implantation.
The prevalence, clinical and prognostic relevance of frailty in a cardiac rehabilitation setting has not yet been well
characterised, despite the increasing frequency of elderly patients in cardiac rehabilitation, where frailty is likely to
influence the onset, type and intensity of the exercise training programme and the design of tailored rehabilitative
interventions for these patients.
Therefore, we need to start looking for frailty in elderly patients entering cardiac rehabilitation programmes and become
more familiar with some of the tools to recognise and evaluate the severity of this condition. Furthermore, we need to
better understand whether exercise-based cardiac rehabilitation may change the course and the prognosis of frailty in
cardiovascular patients.
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We belong to an ageing world where people are living
longer. In 2030, progressive population ageing will lead
to an increase in the proportion of people aged over 65
years from 17.4% to 25.6%, and the population of eld-
erly people will almost double in Europe from 87.5 mil-
lion in 2010 to 152.6 million in 2060.1 Progressive
ageing is associated with geriatric syndromes (particu-
larly frailty) that pose a severe burden on health sys-
tems. Therefore, there is a need to understand these
syndromes better, with particular attention to the rele-
vance of frailty in the context of care of older cardiac
patients, including cardiac rehabilitation (CR).
Frailty and its relationship with disability and
comorbidity
Frailty is characterised by impairment in many
domains (e.g. physical, psychological and social) with
consequent effects on mortality, hospitalisation,
dependence, disability and significant healthcare cost.2
Although varying definitions exist, there is a common
thread in that frailty is a dynamic age-related vulner-
ability3 characterised by declining function, associated
with a loss of physiological reserves of multiple organs
or systems, and an increased risk of negative outcomes,
such as institutionalisation and death.4,5 The patho-
physiological mechanisms underlying the development
or progress of a frailty status are multifactorial, and
include inflammatory mechanisms, the hypothalamic–
hypophysary axis, and anabolic–catabolic hormone
imbalance.5 Studies show that frailty, independently
of how it is measured, is significantly and independently
correlated to medical outcomes.6,7 Despite the rele-
vance of frailty as a prognostic indicator, uncertainty
remains regarding its definition, its measurement, the
feasibility of its measurement in clinical practice and
whether such measurements can be influenced by inter-
ventions or describe the progress or deterioration of
health status. This is particularly true in the CR setting,
where the increasing age of patients admitted to CR
poses problems in individualising models of clinical
evaluation and interventions.
The extent of frailty is not determined purely by the
magnitude and frequency of comorbidity or disability,
as patients with the same comorbidity or disability may
present with different degrees of frailty or no frailty at
all. On the other hand, a patient may be frail with few
comorbidities or disabilities.8 Based on data from the
Cardiovascular Health Study, about 25% of older
patients show signs of frailty without either multiple
comorbidities or disabilities.9 Disability may be a con-
sequence of frailty but, alternatively, disability may be
closely linked to the development or worsening of
frailty status; in particular, so-called primary frailty,
described in older patients without overt pathological
conditions, and can lead to diseases or disability and to
secondary frailty that in turn may worsen the pheno-
typic presentation of frailty.10 The recognition and
measurement of frailty and the possibility of modifying
this status are important issues within and beyond
modern geriatric medicine.
Frailty models
Two main models of frailty have been proposed. The
phenotype model proposed by Fried et al. views frailty
as a biological syndrome resulting from cumulative
decline across multiple physiological systems.4 The
model advanced by Rockwood et al. views frailty as a
multidimensional risk state that can be measured more
by the quantity than by the nature of health
problems.11–13
Primary frailty model: the phenotype model. According to
Fried et al., a wealth of epidemiological or observa-
tional studies has described the presence of frailty in
the general elderly population (physiological ageing).
In this environment frailty has been defined as ‘primary
frailty’, a phenotypic presentation involving decline in
physical functioning and psychological status, without
taking into consideration associated diseases or patho-
logical conditions. Fried’s phenotype frailty index4
(PFI) has been widely adopted: it was derived from
an analysis of five health domains: nutrition; physical
exhaustion; low energy expenditure (or inactivity
status); mobility; and muscular strength (Table 1).
Deterioration of each of these domains was scored as
1 if present or 0 if absent, giving a potential score span-
ning from 0 to 5. The phenotype model classified three
categories: robust (no deterioration); pre-frail (one or
two function deterioration); or frail (three or more
function deterioration). This categorisation was inde-
pendently correlated with outcomes, such as survival,
falls, disability and institutionalisation.4
Secondary frailty model: accumulation of deficit model. The
conceptualisation of frailty proposed by Rockwood
et al. considers the accumulation of multiple deficits
such as symptoms, signs, disabilities, pathological con-
ditions and abnormal laboratory values (secondary
frailty).11–14 In this model, a frailty index (FI) was mea-
sured as deficit accumulation (Table 2). Each deficit can
be coded as binary (1 or 0) or ordinal (0, 0.5, 1). This FI
is the sum of the deficit values divided by the total
number of deficits listed (e.g. 10 deficits present out
of 40 gives a FI ratio of 10/40¼ 0.25) and is signifi-
cantly correlated with outcomes; for example, with
each unit increase the hazard rate for mortality increases
by 4%.15
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Frailty indices adopting the deficit accumulation
model can be derived from different numbers and
types of variables, provided certain criteria are ful-
filled.14 The number of deficits, rather than a single
deficit, is related to adverse outcomes, as the final
number reflects a global measure of vulnerability. A
patient with a score of less than 0.2 would be con-
sidered not frail, an increasing score indicates an
increased level of frailty. In order for a FI to be able
to capture sufficient features or risk factors for frailty, it
should include at least 40 items, covering several health
domains, such as physical, cognitive, psychological and
social.14 It is important to note that frailty increase
parallels ageing, independently of baseline frailty, and
evaluation of interventions to reduce frailty must take
into consideration a natural physiological increase in
frailty with age.
Frailty assessment
Assessing instruments. An important issue in the clinical
environment, and particularly in primary care, is that
the measurement of frailty based on either the pheno-
typic or deficit accumulation model may be complex
and time consuming. There are, however, alternative
instruments to apply in clinical practice for screening
and evaluating frailty in the general population
(Table 3). Some follow the phenotypic model,16–19
others consist of administered or self-administered
questionnaires,20,21 and some require clinical evalu-
ation22 or task performance and measurement such as
the Edmonton frailty scale (EFS).23 Some scales are
designed to be screening instruments18 and others to
be more multifaceted tools requiring comprehensive
geriatric assessment (CGA).24 They are designed for
use with different groups of individuals, and differ in
their feasibility and prognostic ability.
Despite these differences, all scales were predictive of
all-cause mortality or of relevant elderly outcomes, in
most cases independently from other prognostic indi-
ces. A recent comparison of these scales in the SHARE
survey25 showed some differences in their prognostic
predictive ability. Receiver operating characteristic
(ROC) curves showed that FI derived from the deficit
accumulation model, FI derived from CGA (FI-CGA)
and EFS performed slightly better than other scales.
As CGA, consisting of a multidimensional assess-
ment of several health domains, is the cornerstone of
modern geriatric care,26 FI-CGA may be considered as
one of the best models to measure frailty. The FI-CGA,
validated in the Canadian Study of Health and Aging
(CSHA), a large population-based study,24–27 explored
10 domains, assigning a score to each domain and con-
structing a frailty categorisation: mild (FI-GCA 0–7),
Table 1. Phenotype frailty index.4
Domain Criterion Score








Low energy expenditure Lower category of physical activity by a validated
questionnaire (e.g. MLTAQ-short version)**
Kcals/week expended
Men: <383 Kcal/week¼ 1
Women: <270 Kcals/week¼ 1
Mobility Gait speed on a 4.5 meter walk, stratified by
gender and height
Men height 173 cm and time 7 s¼ 1
Men height >173 cm and time 6 s¼ 1
Women height 159 cm and time 7 s¼ 1
Women height >159 cm and time 6 s¼ 1
Muscular strength Lower category of muscular strength measured
by hand handgrip, stratified by gender and BMI
Men BMI 24 and strength 29¼ 1
Men BMI 24.1–26 and strength 30¼ 1
Men BMI 26.1–28 and strength 30¼ 1
Men BMI >28 and strength 32¼ 1
Women BMI 23 and strength 17¼ 1
Women BMI 23.1–26 and strength 17.3¼ 1
Women BMI 26.1–29 and strength 18¼ 1
Women BMI >29 and strength 21¼ 1
BMI: body mass index.
*Orme J, Reis J and Herz E. Factorial and discriminate validity of the Center for Epidemiological Studies depression (CES-D) scale. J Clin Psychol 1986;
42: 28–33.
**Taylor HL, Jacobs DR, Schucker B, et al. Questionnaire for the assessment of leisure time physical activities. J Chron Dis 1978; 31: 741–755.
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moderate (FI-CGA 7–13) and severe (FI-CGA> 13)
frailty.24 The same data from CGA can be analysed
by counting the deficit according to the deficit accumu-
lation model,3 and both types of measurements have
been correlated to outcome.27
Extensive reports in the literature have shown that
frailty can indeed be measured with relative ease even in
hospital settings, for patients in general medical
wards,6,7,28–31 geriatric units,32,33 survivors of intensive
care units or emergency departments,34,35 including
Table 2. Frailty index based on the deficit accumulation model.14
List of 40 variables included in the FI Cut point
Help bathing Yes: 1 No: 0
Help dressing Yes: 1 No: 0
Help getting in/out of chair Yes: 1 No: 0
Help walking around house Yes: 1 No: 0
Help eating Yes: 1 No: 0
Help groomirg Yes: 1 No: 0
Help using toilet Yes: 1 No: 0
Help up/down stairs Yes: 1 No: 0
Help lifting 10 lbs Yes: 1 No: 0
Help shopping Yes: 1 No: 0
Help with housework Yes: 1 No: 0
Help with meal preparations Yes: 1 No: 0
Help taking medications Yes: 1 No: 0
Help with finances Yes: 1 No: 0
Lost more than 10 lbs in last year Yes: 1 No: 0
Self-rating of health Poor: 1 Fair: 0.75 Good: 0.5 V. good: 0.25 Excellent: 0
How health has changed in last year Worse: 1 Better/same: 0
Stayed in bed at least half of the day due
to health (in the last month)
Yes: 1 No: 0
Cut down on usual activity (in the last month)Yes: 1 No: 0
Walk outside <3 days: 1 >3 days: 0
Feel everything is an effort Most of the time: 1 Some time: 0.5 Rarely: 0
Feel depressed Most of the time: 1 Some time: 0.5 Rarely: 0
Feel happy Most of the time: 1 Some time: 0.5 Rarely: 0
Feel lonely Most of the time: 1 Some time: 0.5 Rarely: 0
Have trouble getting going Most of the time: 1 Some time: 0.5 Rarely: 0
High blood pressure Yes: 1 Suspect: 0.5 No: 0
Heart attack Yes: 1 Suspect: 0.5 No: 0
CHF Yes: 1 Suspect: 0.5 No: 0
Stroke Yes: 1 Suspect: 0.5 No: 0
Cancer Yes: 1 Suspect: 0.5 No: 0
Diabetes Yes: 1 Suspect: 0.5 No: 0
Arthritis Yes: 1 Suspect: 0.5 No: 0
Chronic lung disease Yes: 1 Suspect: 0.5 No: 0
MMSE <10: 1 11–17: 0.75 18–20: 0.5 20–24: 0.25 >24: 0
Peak flow (l/min) <340 (men); <310 (women)
<18, >30 (men); <18.5, >30 (women)
<12 (men); <9 (women)
9>>>>>=
>>>>>;
1 point awarded for each criterion
<29–32 (men); <17–21 (women)
>10 (men and women)
>16 (men and women)
Body mass index (BMI)
Shoulder strength (kg)
Grip strength (kg)
Rapid pace walk for 20 ft (s)
Usual pace walk for 20 ft (s)
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critical oncological36 or dialysed patients37 (Table 4). In
these settings, frailty has been assessed by a variety of
tools including the FI-CGA instrument,28,30 the CSHA
clinical frailty scale6,7,31,34,37 and the phenotypic
model.29,35,36 Frailty varied from 20% to 82%, accord-
ing to the scale and the population examined.
A direct comparison among some of these scales in
hospitalised patients aged over 65 years was reported
by Pilotto et al., who described an innovative frailty
instrument based on a modified CGA (CGA-based
multidimensional prognostic index – MPI).38 The
MPI integrated data from eight domains such as
Table 3. Frailty instruments in general population.






15 items, focusing on 4 functional domains:
physical (9 items), cognitive (1 item),
social (3 items), psychological (2 items).
A score >4 (out of 15) can be considered frail.
Schuurmans et al. J








The 2d subscale evaluates 3 domains and 15 items
about physical (8 items), social (3 items), and
psychological factors (4 items), including 1 item
on cognition. Scores range from 0 to 15.
A score of >5 is associated with frailty.
Gobbens et al. J Am Med




Phenotypic model 5 Adapted phenotypic frailty items (grip strength
and 4 self-reported items: fatigue, loss of
appetite and/or eating less than usual, difficul-
ties climbing stairs and/or walking 100 m, and
low level of physical activity).
Frailty categories: non-frail, pre-frail and frail.
Romero-Ortuno, Geriatr





Phenotypic model 3 Items: 1) unintentional weight loss; 2) inability
to rise from a chair 5 times without the use of
arms; 3) low energy level.
Robust: 0 component; pre-frail: 1 component;
frail: 2 or 3 components.
Ensrud, et al. J Am Geriatr
Soc 2009; 57: 492–498.
FRAIL scale Questionnaire
(phenotypic model)
5 Item (fatigue, resistance, ambulation, illnesses,
loss of weight).
Pre-frail: 1–2 deficits
Frail: 3 deficits or more
Abellan Van Kan, et al. J







6 Items: social, nutrition, exhaustion, mobility,
cognition, physical activity.
Plus GP opinion.







17 Simple questions or tasks, assessing cognition,
self-perceived health, dependence for ADL,
social support, medication use, nutrition,
mood, continence and functional performance.
Each item is given from 0 to 2 points, and
a frailty state is assigned to a global scores
>8/17.









Frailty assessment tool in the domains of mobility,
energy, physical activity, and function.
Scale ranging from a level of 1 (very fit) to 8 (very
severely frail)
Rockwood, et al. Can Med









Geriatric assessment of several domains: cogni-
tion, disability, mood and motivation, commu-
nication, mobility, balance, bowel/bladder
function, nutrition, social resources and
comorbidity. Can be reported as a continuous
(deficit accumulation) or a categorical score.
Jones, et al. J Am Geriatr
Soc 2004; 52: 1929–
1933.
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disability (basic and instrumental activities of daily life
– BADL-IADL), cognitive, nutritional, comorbidities,
drug use, risk of developing pressure sores and cohabit-
ation status. ROC curve analysis for the endpoint of
mortality showed good performance of MPI compared
with FI and FI-CGA.
Value of frailty instruments in measuring outcome
Frailty depends on several interrelated factors and can
change over time. As frailty is a dynamic process influ-
enced by progressive aging,39,40 it is uncertain whether
it can be used as an outcome measure of an interven-
tion.41 Therefore, an evaluative outcome instrument to
measure frailty with reliable clinimetric properties is
needed.9 A review of many commonly adopted frailty
instruments in clinical practice has analysed their clini-
metric properties (agreement, construct validity,
responsiveness, interpretability, content validity,
internal consistency, floor and ceiling effect).42 Frailty
instruments have mostly been validated as prognostic
tools, but their ability for capturing intervention-
induced changes in frailty over time is unclear. At the
present time, and with caution, the FI calculated
according to the deficit accumulation model11,12
appears, from the clinimetric standpoint, the most suit-
able and reliable to capture changes in frailty over time.
Using the frailty index as a tool to estimate the increase
in healthcare resources required for different levels of
frailty may help to identify the investment needed to
reduce frailty in the community.43,44
Frailty in cardiology
With progressive population ageing, the burden of car-
diovascular disease has become prevalent as a cause of
mortality, morbidity and disability.45 Therefore, there
has been a recent surge of interest in evaluating frailty
Table 4. Frailty instruments in hospital environment.
Frailty tool Setting Patient numbers/age Frailty Reference












90 Patients mean age
76 6.4 years
20% Stiffler, et al. J Emerg Med 2013;
45: 291–298.




Not reported Wallis, et al. Q J Med 2015; 108:
943–949.








Singh, et al. Age Ageing 2012; 41:
242–246.
Clinical frailty scale General medical
wards
421 critically ill adults
aged > 50 years
32.8% Bagshaw, et al. CMAJ 2014; 186:
E95–102.
Phenotype ICU survivors 22 Patients
mean age 77 years
82% Baldwin, et al. J Crit Care 2014;
29: 401–408.




mean age 82.9 years
Not reported Basic, et al. J Aging Health 2015;
27: 670–685.





mean age 64 years
33% Kahlon, et al. CMAJ 2015; 187:
799–804.








Handforth, et al. Ann Oncol 2015;
26: 1091–1101.
Clinical frailty scale On dialysis 390 Patients 26% Mild–mod.
53% severe
Alfaadel, et al. Clin J Am Soc
Nephrol 2015; 10: 832–840.
Frailty index based on
a CGA (FI-CGA)








Geriatric units 2033 Patients
mean age 79.8 years
Grade 2: 36.5%
Grade 3: 21.6%
Pilotto, et al. PLoS One 2012; 7:
e29090.
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in patients with cardiovascular conditions. Frailty has
been assessed in patients affected by various cardiovas-
cular diseases, and many of the instruments adopted
have demonstrated prognostic value;46–48 they may
have value in defining guidelines for cardiac patients’
management during hospitalisation and after discharge.
Each of the instruments proposed has its own grade of
complexity and prognostic information. In general,
even as a sole prognostic indicator and with the
above limitations, instruments describing a frailty
status in several populations of cardiac patients have
outscored other more usually adopted prognostic
indicators.46–48
Frailty in elderly patients with acute coronary
syndrome or percutaneous transluminal
coronary angioplasty
Many studies have evaluated frailty in elderly patients
after an acute coronary syndrome (ACS) or percutan-
eous transluminal coronary angioplasty (PTCA) by
using several instruments, such as the phenotypic
model (PFI),4 the CSHA clinical frailty scale,22 or the
EFS.23 In this setting frailty ranged from 10% to 48%,
and higher levels of frailty were associated with worse
outcomes (Table 5).47,49–55
These studies showed an independent added prog-
nostic value of frailty assessment, and although larger
studies are needed to refine risk prediction models, it is
suggested that clinicians and researchers should con-
sider how they can embed frailty measurement into
clinical practice.
Frailty in elderly patients undergoing cardiac surgery
In the current era, the elderly represent the fastest
growing group of patients referred for cardiac surgery,
with the proportion of patients aged 75 years or older
rising from 16% in 1990 to 25% in most recent esti-
mates.56 These complex and often frail patients are at
increased risk of falls, prolonged hospitalisation and
mortality after surgery.56,57 For this reason, many
groups have evaluated preoperative frailty to increase
prognostic capability.56,58,59
Recently, Afilalo et al.56 in a population of 152 eld-
erly patients (>70 years) undergoing coronary artery
bypass graft and/or valve surgery, evaluated the incre-
mental prognostic value of four different frailty scales
and of three disability scales compared with classic car-
diac surgery risk scores. Frailty scales adopted in this
study were the Fried frailty scale,4 the expanded Fried
frailty scale (addition of cognitive impairment and
depressed mood),60 the four-item MacArthur study of
successful ageing frailty scale subdimensions (gait
speed, handgrip strength, inactivity, cognitive
impairment),61 and gait speed alone. Compared with
the Parsonnet score62 or the Society of Thoracic
Surgeons predicted risk of mortality or major morbid-
ity score (STS-PROMM),63 the addition of frailty
and disability provided independent incremental
value and improved model discrimination for in-hospi-
tal postoperative mortality or major morbidity. Thus,
the integration of frailty, disability and risk scores
should better characterise elderly patients referred for
cardiac surgery and identify those who are at increased
risk.
Transvalvular aortic valve replacement
Transvalvular aortic valve replacement (TAVR) is a
successful intervention in elderly patients with aortic
stenosis, and patients after TAVR benefit from CR des-
pite their older age and clinical complexity and frailty.64
Several studies have recently described the added prog-
nostic value of frailty evaluation over standard criteria
in elderly patients undergoing TAVR.
A modified Fried frailty score (gait speed, grip
strength, serum albumin and activities of daily living)
in very old patients was independently associated with
increased one-year mortality after TAVR.65 A frailty
index based on the assessment of cognition, mobility,
nutrition, BADL and IADL predicted functional
decline after TAVR, suggesting that this index might
identify elderly patients who could potentially benefit
from additional geriatric interventions.66 Another
study reported that a multidimensional geriatric assess-
ment-based score (including cognition, nutrition,
mobility, BADL, plus a ‘home-made’ frailty index) pre-
dicted one-year mortality and major adverse cardiovas-
cular and cerebral events (MACCE) after TAVR in
patients aged over 70 years.67 Recently, a PARTNER
trial sub-study found that, in older recipients of TAVR,
frailty, assessed using a modified frailty phenotype
model (serum albumin, dominant handgrip strength,
gait speed and activities of daily living), independently
predicted all-cause mortality or poor outcome at one
year.68
A recent review of six studies and 4756 patients
undergoing cardiac surgery or TAVR concluded that
frail elderly patients have a higher likelihood of mor-
tality, morbidity, functional decline and MACCE fol-
lowing cardiac surgery or TAVR, regardless of the
frailty assessment tool.69
All of the studies65–69 have reported frailty measure-
ment before surgery or intervention and utilised it as an
added prognostic tool for later events, but none of these
studies has evaluated frailty in the immediate post-
operative period, which is usually unstable and there-
fore not well suited for measurements of frailty that
require clinical stability.
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Frailty in elderly patients with chronic heart failure/
left ventricular assist device
Frailty prevalence in chronic heart failure (CHF)
patients ranges from 15% to 74%, depending on the
population and assessment method. The FRAIL-HF
study70 reported that 70.2% of non-dependent older
patients hospitalised for CHF are frail, as evaluated
by the Fried criteria. In these patients a superimpos-
ition of primary frailty associated with progressive
ageing and frailty secondary to CHF is difficult to dis-
entangle, as both share similar physiopathological
mechanisms, such as anabolic–catabolic and
neurohormonal imbalance, systemic inflammation,
increased oxidative stress or mitochondrial dysfunc-
tion.71 In CHF frailty is consistently associated with
poor outcome, quality of life, disability or
hospitalisation.72–80
McNallan et al. reported that frailty, measured by
the Fried criteria, was an independent predictor of hos-
pitalisations in community patients with CHF.72
Cacciatore et al., utilising the Lachs frailty staging
score (based on sensorial compromise, cognitive
impairment, urinary incontinence, poor social support
and disability), found that the probability of death in
patients with CHF and a frailty score of 3 was 100% as
Table 5. Frailty tools in acute coronary syndrome or percutaneous transluminal coronary angioplasty.
Author
Patient








NSTEMI CSHA clinical frailty
scale >5
48.5% Frailty was independently associated
with 1-year mortality after adjusting













Green score was an independent out-
come predictor (per point; mortal-
ity: HR 1.25, 95% CI 1.15–1.36,
P¼ 0001)





STEMI CSHA clinical frailty
scale >6
35.5% CSHA-CFS >6 (P¼ 0.002, OR 16.69)
was an independent predictor of



















After adjustment for covariates, frailty
was independently associated with
cardiovascular death, MI, or stroke:
pre-frail vs. not-frail, HR: 1.33; 95%
CI 1.15–1.54; P< 0.001; frail vs. not-










30% After adjusting for confounders, the HR
for mortality for EFS >7 compared
with EFS 0–3 was 3.49 (95% CI 1.08–
7.61; P< 0.002)
















Three-year mortality was 28% for frail
patients, and 6% for non-frail
patients. Frailty, comorbidities and
SF-36 improved prediction of death









PTCA CSHA clinical frailty
scale 5
Frail: 10.8% Frailty was associated with increased
30-day (HR 4.8, 95% CI 1.4–16.3,
P¼ 0.013) and 1 year mortality (HR
5.9, 95% CI 2.5–13.8, P< 0.001)












¼¼¼¼ Frailest group (0.25) had twice the
multivariable-adjusted mortality risk
of those in the least frail group
(<0.10) (HR 2.02, 95% CI 1.46–2.79)
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compared with 55% in patients with CHF and a frailty
score of 1.73 Lupon et al. found that a scale based on
evaluation of BADL–IADL, cognitive function, psy-
chological and social status, was independently corre-
lated with quality of life, hospitalisation and
mortality.74,75
Volpato et al.76 and Chiarantini et al.,77 utilising the
short physical performance Battery (SPPB), a test mea-
suring lower extremity physical performance by walking
speed, balance test and ability to stand up from a chair,78
found in patients hospitalised for CHF that poor SPPB
scores at hospital discharge were predictive of a greater
risk of rehospitalisation or death. Even single items such
as low gait speed or low grip strength in community
living CHF patients were correlated with hospitalisation
at follow-up,79 and the Barthel index of disability and
cognitive compromise correlated with six months mor-
tality in CHF patients admitted to hospital.80
Recently, Dunlay et al. found, in a small cohort
study of advanced CHF patients undergoing left
ventricular assist device (LVAD) implantation, that
pre-intervention frailty was associated with increased
mortality.81 This suggests that frailty assessment may
be relevant for identifying suitable candidates for this
invasive procedure. There is evidence that LVAD inter-
vention82 and heart transplantation83 improve some
biological, structural and functional markers of frailty
associated with CHF.
Frailty and CR
Despite the negative bias for referring very elderly patients
with complex comorbidities and frailty to CR,84 at pre-
sent patients older than 75 years represent about one third
of those referred to CR.85 Thus frailty might be present in
a substantial proportion of patients admitted to CR, and
this condition needs specific consideration.
The prevalence of frailty and its clinical and prog-
nostic relevance has not as yet been well characterised
in the environment of CR, although many studies have
reported the measurement of frailty in patients with
coronary syndromes in intensive care units or in cardi-
ology wards,49–52 and others have underscored the close
link between frailty and CHF.71–80 As patients after
ACS or CHF represent a considerable proportion of
those participating in CR,85,86 we may suggest that
frailty measurement should be performed in CR, to
help plan their management and estimate their
prognosis.
Frailty complicates the management of elderly
patients, because it may affect the type and timing of
diagnostic procedures and pharmacological and non-
pharmacological treatment. Baseline physical function
evaluation should be tailored to their physical condi-
tions, and the CR programme should be individualized
on the basis of their functional compromise and disabil-
ity.87 Pharmacological treatment should be carefully
weighted, balancing guideline recommendations with
a prudent approach, because associated comorbidities
may increase iatrogenic complications. In community
living or institutionalised frail elderly patients tailored
exercise training has improved to some degree their
physical function and quality of life.88–93 Individuals
at higher risk of disability at baseline derive the most
benefit from these types of interventions90 by increasing
gait speed, improving balance and performance in
activities of daily life,91 or SPPB.92 However, it is still
uncertain whether these positive results can be applied
to CR patients. Particularly in patients with CHF,
structured exercise training improves the neurohormo-
nal, inflammatory and metabolic parameters of CHF-
related frailty and has favourable effects on physical
function, functional capacity and quality of life.70 It is
still uncertain whether therapeutic interventions
(pharmacological and non-pharmacological) that have
proved successful in younger CHF patients will be suc-
cessful in elderly patients, because the majority of ran-
domised clinical trials in CHF do not include very
elderly patients with frailty. However, from a practical
standpoint, exercise-based CR programmes should be
implemented, with caution, aimed at obtaining
improvement in physical mobility, functional capacity,
fall prevention, disability prevention or decreased pro-
gression, and improvement in quality of life.
Nutrition is also a very important part of the multi-
dimensional intervention in CR,94 particularly in very
elderly and frail or sarcopenic/cachectic patients, where
a poor nutritional status is one of the main
Table 6. Recommended tools for frailty evaluation in cardiac rehabilitation.
Tool Items Reference
Edmonton frailty scale 17 Simple questions or tasks, assessing cognition, self-perceived health,
dependence for ADL, social support, medication use, nutrition, mood,
continence and functional performance. Each item is given from 0 to 2
points, and a frailty state is assigned to a global score >8/17.
23
Clinical frailty scale from
the CSHA study
Frailty assessment tool in the domains of mobility, energy, physical activity and
function. Scale ranging from a level of 1 (very fit) to 8 (very severely frail).
22
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pathophysiological mechanisms for frailty. Recent stu-
dies suggest that improving nutritional status may
reduce the risk of frailty.95,96 Furthermore, a recent
review has shown that nutrition may improve the func-
tional outcome of elderly and frail patients.97
Future directions
Step 1: Feasibility of frailty measurement
in the setting of cardiac rehabilitation
Assessment of frailty in the CR requires additional
time within routine clinical evaluation. While the add-
ition of frailty tools to the management of the elderly
patient holds promise, multiple topics should be clari-
fied before recommending their widespread clinical
application. These include identifying which of the
many tools provides the best combination of perform-
ance and facility, with clear definition of standardised
values.
A variety of instruments for measuring frailty could
be tested in CR and compared regarding their practical
feasibility, trying to achieve a compromise between sim-
plicity of administration and completeness of frailty
domain representation. It is important to stress that
the proposed tools should be selected among those
already validated in hospitalised patients with cardio-
vascular disease, and particularly in patients after an
acute coronary event or with CHF, who are likely to
be similar to those admitted to CR programmes. It is
uncertain whether tools validated before the index
event for CR or in other clinical settins may be applic-
able to patients after a cardiovascular acute event/
intervention.
The EFS could be used as representative of a user-
friendly but comprehensive instrument (see also Table
6).23 The EFS is easy to administer, requiring less than
5 minutes to perform; it can be administered by any
professional (nurse, technician) or student, and it has
been validated in elderly patients after acute coronary
syndromes,49 where it was found to correlate with prog-
nosis. It also includes two clinical performance items
interrogating cognition (clock test) and functional per-
formance (timed up and go – TUG test). Tools based
on the deficit accumulation model, such as the 40-item
FI adopted by Singh et al.98 adopted in elderly patients
in acute geriatric rehabilitation wards, could be used to
assess prognosis or guide intervention planning, or for
evaluating frailty changes with time; however, in the
busy CR world tools based on the deficit accumulation
model may be cumbersome to apply. Therefore, an
easy-to-use tool based on a standardised subjective
evaluation of frailty would be more easily accepted
and adopted, such as the Canadian Study on Health
and Ageing clinical frailty scale22 (Table 6).
The authors, through the European Association of
Preventive Cardiology (EAPC), seek to evaluate the
feasibility of applying these or more tools in CR centres
through a European registry study in all elderly patients
aged over 75 years. This would have the advantage of
familiarising the cardiologist working in CR with frailty
instruments, while screening for the frequency of frail
elderly patients enrolled in European cardiac rehabili-
tation centres.
Some practical points should be discussed, such as
who carries out these measurements. It is the authors’
opinion that, due to the simple nature of the data to be
collected, any health professional (cardiologist, cardi-
ologist in training, nurse, allied health professional or
medical student) could perform a frailty measurement,
provided a uniform method of data collection is agreed
and shared within and between CR centres.
The timing of frailty assessment in CR is also rele-
vant. It is the authors’ opinion that frailty should be
measured at admission to CR if the patient is already
stable, or later as soon as clinical stability is reached in
the course of the rehabilitative programme. We believe
that this approach is more correct, because before the
acute event or surgery a frailty status may be worsened
by the severity of disease, and may improve after clin-
ical stabilisation is reached in CR. On the other hand,
in patients entering CR after cardiac surgery, surgical
complications in addition to a pre-surgical disability
may limit their function, and it would be wise to wait
for a progressive improvement in physical function
before screening patients for frailty.
Step 2: Frailty and prognosis
It is still uncertain whether the addition of any frailty
score/index to routine assessments in elderly patients
entering CR may increase the prognostic capacity in
that setting.
Therefore, these instruments should be tested in the
CR environment as prognostic indicators against
clearly defined endpoints, such as hospitalisation
length, quality of life, disability and compared to trad-
itional prognostic indicators, such as left ventricular
ejection fraction, myocardial ischemia, arrhytmias or
functional capacity. In this regard, a prospective obser-
vational study could be proposed for CR centres in
Europe to evaluate the prognostic ability of frailty
tools. If this is successful, CR practitioners may acquire
an added tool to improve the prediction of outcomes,
and be able to tailor the type and intensity of interven-
tions for frail patients better.
In conclusion, it is the opinion of the authors that
lead CR practitioners should work together with geria-
tricians to become more familiar with frailty instru-
ments and their application in the clinical
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environment in very elderly patients, to improve their
prognostic ability and to design specific tailored inter-
ventions in complex patients. Further large studies can
then be undertaken, to determine if the use of frailty
measurement improves outcomes for elderly and frail
patients admitted to CR.
Key messages
. Frailty is a condition specifically present in the eld-
erly population, characterised by declining function
of multiple physiological systems associated with
loss of physiological reserves.
. Two main models are proposed for frailty: the
phenotypic model (primary frailty) or the deficits
accumulation model (secondary frailty).
. Different instruments have been used to measure
frailty.
. Frailty correlates to medical outcomes in the elderly,
independently of how it is measured.
. Frailty has been shown to have prognostic value for
patients with coronary artery disease, cardiac sur-
gery, TAVR, CHF and LVAD.
. The prevalence, clinical and prognostic relevance of
frailty in a CR environment has not yet been well
characterized.
. The presence and severity of frailty may
modulate the CR programme through tailored
interventions.
. We need to understand better to what extent CR
may change the course and the prognosis of frailty,
especially in cardiovascular patients, because exer-
cise training and nutrition are well-known corner-
stones in the management of elderly cardiac patients.
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